Jacobson Allan Steven 4

Accession 0001579003-25-000005

CIK 0001070081other

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 5:20 PM ET

Size

36.4 KB

Accession

0001579003-25-000005

Insider Transaction Report

Form 4

Period: 2025-11-24

PTC THERAPEUTICS, INC.PTCT

Jacobson Allan Steven

Director

Transactions

Exercise/Conversion
Common Stock
2025-11-24$11.23/sh+5,701$64,022→ 23,152 total
Sale
Common Stock
2025-11-24$80.13/sh−5,701$456,821→ 17,451 total
Exercise/Conversion
Common Stock
2025-11-24$18.01/sh+6,100$109,861→ 23,551 total
Sale
Common Stock
2025-11-24$80.15/sh−6,100$488,915→ 17,451 total
Exercise/Conversion
Common Stock
2025-11-25$11.23/sh+6,299$70,738→ 23,750 total
Sale
Common Stock
2025-11-25$82.63/sh−2,264$187,074→ 21,486 total
Sale
Common Stock
2025-11-25$83.93/sh−2,510$210,664→ 18,976 total
Sale
Common Stock
2025-11-25$84.45/sh−1,125$95,006→ 17,851 total
Sale
Common Stock
2025-11-25$85.24/sh−400$34,096→ 17,451 total
Exercise/Conversion
Common Stock
2025-11-25$18.01/sh+7,900$142,279→ 25,351 total
Sale
Common Stock
2025-11-25$82.58/sh−2,460$203,147→ 22,891 total
Sale
Common Stock
2025-11-25$83.38/sh−3,502$291,997→ 19,389 total
Sale
Common Stock
2025-11-25$84.47/sh−1,238$104,574→ 18,151 total
Sale
Common Stock
2025-11-25$85.32/sh−700$59,724→ 17,451 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−5,701→ 6,299 total
Exercise: $11.23Exp: 2027-01-02→ Common Stock (5,701 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-24−6,100→ 7,900 total
Exercise: $18.01Exp: 2028-01-02→ Common Stock (6,100 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−6,299→ 0 total
Exercise: $11.23Exp: 2027-01-02→ Common Stock (6,299 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−7,900→ 0 total
Exercise: $18.01Exp: 2028-01-02→ Common Stock (7,900 underlying)

Footnotes (9)

[F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 12, 2025
[F2]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F3]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $82.00 to $82.98 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F4]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $83.00 to $83.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F5]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F6]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.14 to $85.34 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F7]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $84.00 to $84.97 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F8]This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $85.00 to $85.60 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F9]Currently exercisable.

Documents

1 file

4
form4-11262025_051101.xmlPrimary

Issuer

PTC THERAPEUTICS, INC.

CIK 0001070081

→

Entity typeother

Related Parties

filerCIK 0001579003

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 5:20 PM ET
Size: 36.4 KB

View on SEC.gov